Patents by Inventor Sybille Albrecht

Sybille Albrecht has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnostic and therapeutic use of antibodies against the urokinase receptor
    Patent number: 7399468
    Abstract: The invention concerns a method and a reagent kit for detecting cells in a biological sample using a double-fluorescence technique and the diagnostic and therapeutic application of amino acid sequence-specific antibodies against the urokinase receptor having a high affinity for tumour cell-expressed receptors.
    Type: Grant
    Filed: October 26, 2006
    Date of Patent: July 15, 2008
    Assignee: Wilex AG
    Inventors: Thomas Luther, Martin Mueller, Sybille Albrecht, Viktor Magdolen, Olaf Wilhelm, Manfred Schmitt, Nadja Harbeck
  • Diagnostic and therapeutic use of antibodies against the urokinase receptor
    Publication number: 20070066798
    Abstract: The invention concerns a method and a reagent kit for detecting cells in a biological sample using a double-fluorescence technique and the diagnostic and therapeutic application of amino acid sequence-specific antibodies against the urokinase receptor having a high affinity for tumour cell-expressed receptors.
    Type: Application
    Filed: October 26, 2006
    Publication date: March 22, 2007
    Applicant: WILEX AG
    Inventors: Manfred Schmitt, Viktor Magdolen, Thomas Luther, Sybille Albrecht, Martin Muller, Olaf Wilhelm, Nadja Harbeck
  • Expression of signal-peptide-free staphylokinases
    Patent number: 6010897
    Abstract: The invention relates to recombinant staphylokinase polypeptides with plasminogen activator effect and to their production and use. The polypeptides are obtained by expression of DNA sequences which are free from signal-peptide-coding regions.
    Type: Grant
    Filed: May 17, 1997
    Date of Patent: January 4, 2000
    Inventors: Detley Behnke, Bernhard Schlott, Sybille Albrecht, Karl-Heinz Guhrs, Manfred Hartmann
  • Expression of signal-peptide-free staphylokinases
    Patent number: 5801037
    Abstract: The invention relates to recombinant staphylokinase polypeptides with plasminogen activator effect and to their production and use. The polypeptides are obtained by expression of DNA sequences which are free from signal-peptide-coding regions.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: September 1, 1998
    Assignee: medac Gesellschaft fur klinische spezialpraparate mbH
    Inventors: Detlev Behnke, Bernhard Schlott, Sybille Albrecht, Karl-Heinz Guhrs, Manfred Hartmann